The medicine is ready. The patient is still waiting.

It is called CAR-T. Doctors take some of the patient's own immune cells, reprogram them in a lab to recognise their cancer, and put them back. For some people with blood cancers who have run out of options, it works when nothing else has.

The catch has always been that it has to be built individually, for each patient, before it can be given. And while it is being built, the patient still has cancer.

Exactly the right thing. It attacked the build time, hard, for a decade — and it worked. Making the treatment now takes about seven days. One company has already had a seven-day round trip cleared by the regulator for study.

Regulators helped too. In June 2025 the FDA removed a set of restrictions that had limited which hospitals could give these treatments at all.

And yet the wait a patient experiences barely moved.

This is the part that surprised me. In the one study that measured the whole journey, patients spent thirty to forty days simply waiting for insurance to approve the treatment — before the clock that everybody reports even starts.

Only one privately insured patient in twenty-four got approved within fifteen days.

There is a name for what happened here. You fix the slowest step, and the slowest step moves somewhere else. In 2021 it was factory capacity — four in ten eligible patients could not even get a slot. That got solved. It moved to paperwork, referrals, and geography, where no one publishes a number at all.

Everyone measures their own piece honestly. The manufacturer measures the factory. The hospital measures its schedule. The insurer holds the approval. The patient experiences all of it added together — and nobody adds it together.

This is the question that matters, and the answer is yes — but only if you are very strict about what you are allowed to touch.

Some of the waiting is medical. Tests must be run. Sterility must be confirmed. Nothing in what I am proposing shortens any of that, weakens it, or skips it.

But there is a difference between a step that must happen and a step that must happen while everyone waits. A fourteen-day safety test that runs at the same time as everything else costs nothing. The same test, run one-after-another in a queue, costs fourteen days.

The waste is not the safety check. It is where the safety check sits in the line.

Start one stopwatch, from the day the doctor decides to the day the patient is treated. Break it into steps. Give every step an owner. That is it — and it has apparently never been done end to end for this treatment.

Then start the slow steps early instead of in order. Ask the insurer on day one rather than after all the tests. Book the appointment before you are certain of the date, and release it if you must.

And there is a deadline worth building toward. From January 2027, a US rule requires insurers to answer within seven days, publish how long they take, and make the whole thing work through software. The longest piece of paperwork is about to become something you can schedule around — but only if you already know how long yours takes today.